Controversial Italian COVID-19 IVDs Tender Must Not Be A Blueprint For The Future, Says Industry
Pooling of diagnostics resources should be preferred in the long-term
Executive Summary
Italy must ensure that ongoing efforts to tackle the coronavirus crisis do not rely on single suppliers, the country's medtech industry body said after DiaSorin looked likely to be the sole winner of a major COVID-19 diagnostics tender.
You may also be interested in...
Brazil Levels Medtech ICT Tariffs Playing Field
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
Italian Medtech Industry Launches Investment Trends Study
The Italian medtech industry association Confindustria Dispositivi Medici has launched a major survey of the activities and investment strategies of the sector’s almost 4,000 domestic developers and manufacturers.
Spanish Medtech Gets Ad Approval Stamp, Looks To Rekindle Purchasing
Enhancing trust in medical devices and medtech companies is the aim of a new agreement between the Spanish medtech industry and an organization specializing in helping businesses meet and maintain high legal and ethical standards.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: